Enterprise Innovation Institute

Cresilon receives FDA clearance for haemostatic gel technology

Posted on: June 30, 2023

Cresilon, a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, has announced that it has been granted 510(k) clearance from the US Food and Drug Administration for Cresilon Haemostatic Gel (CHG).

Read full post: Read More